Home / Import refusals / SCS-6705454-8/91/1

FDA Import Refusal SCS-6705454-8/91/1 — Merck & Co. Inc

Merck & Co. Inc — FEI 2211017

The FDA refused shipment SCS-6705454-8/91/1 from Merck & Co. Inc (United States) on November 22, 2024. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 22, 2024
Country
United States
Product Category
Drugs and Biologics
Product Code
66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75

Recent inspections

  • 1305632 (NAI Fri Mar 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1283890 (NAI Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1262774 (NAI Fri May 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1264192 (NAI Thu Mar 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1158317 (NAI Thu Nov 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • AEK-9254299-0/10001/1 (Wed Jan 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7515529-9/10002/1 (Wed Aug 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7462726-4/30001/1 (Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-5766294-0/11/1 (Sat Nov 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-7987432-0/11/1 (Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources